Actavis Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ACTAVIS, and what generic and branded alternatives to ACTAVIS drugs are available?
ACTAVIS has three hundred and twenty-three approved drugs.
There are twenty tentative approvals on ACTAVIS drugs.
Summary for Actavis
US Patents: | 0 |
Tradenames: | 227 |
Ingredients: | 216 |
NDAs: | 323 |
Patent Litigation for Actavis: | See patent lawsuits for Actavis |
PTAB Cases with Actavis as petitioner: | See PTAB cases with Actavis as petitioner |
Drugs and US Patents for Actavis
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Actavis | OXALIPLATIN | oxaliplatin | INJECTABLE;INTRAVENOUS | 204880-001 | Mar 5, 2018 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Actavis Labs Fl Inc | RISPERIDONE | risperidone | TABLET, ORALLY DISINTEGRATING;ORAL | 076996-004 | Apr 19, 2011 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Actavis Elizabeth | TICLOPIDINE HYDROCHLORIDE | ticlopidine hydrochloride | TABLET;ORAL | 075253-001 | Aug 20, 1999 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Actavis Labs Fl | GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE | guaifenesin; pseudoephedrine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 091071-001 | May 27, 2015 | OTC | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Actavis
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Actavis Labs Ut Inc | LOXITANE IM | loxapine hydrochloride | INJECTABLE;INJECTION | 018039-001 | Approved Prior to Jan 1, 1982 | 3,546,226 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for ACTAVIS drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
Similar Applicant Names
Here is a list of applicants with similar names.